Adult T cell leukemia/lymphoma (ATL) is a neoplasm linked to human T-lymphotropic virus type-1 (HTLV-1) infection and is refractory to current combination chemotherapy. A large genomic and transcriptomic study of ATL now provides detailed insight into the molecular lesions implicated in the development of this T cell malignancy.
References
Matsuoka, M. & Jeang, K.T. Oncogene 30, 1379–1389 (2011).
Ishitsuka, K. & Tamura, K. Lancet Oncol. 15, e517–e526 (2014).
Matsuoka, M. & Yasunaga, J. Curr. Opin. Virol. 3, 684–691 (2013).
Kataoka, K. et al. Nat. Genet. 47, 1304–1315 (2015).
Nakagawa, M. et al. J. Exp. Med. 211, 2497–2505 (2014).
Goon, P.K. et al. J. Infect. Dis. 189, 2294–2298 (2004).
De Keersmaecker, K. et al. Nat. Genet. 45, 186–190 (2013).
Palomero, T. et al. Nat. Genet. 46, 166–170 (2014).
Young, R.M. et al. Semin. Hematol. 52, 77–85 (2015).
Ysebaert, L. & Morschhauser, F. Expert Opin. Investig. Drugs 20, 1167–1174 (2011).
El-Gamal, D. et al. Blood 124, 1481–1491 (2014).
Ogura, M. et al. J. Clin. Oncol. 32, 1157–1163 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Vicente, C., Cools, J. The genomic landscape of adult T cell leukemia/lymphoma. Nat Genet 47, 1226–1227 (2015). https://doi.org/10.1038/ng.3428
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3428
- Springer Nature America, Inc.